Last checked at 26 May 2020 11:53
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan | |||
Period of return: | From: | 1 November 2019 | To: | 30 April 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 153,724 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 370,000 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 388,348 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 135,376 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares | |||
Period of return: | From: | 1 November 2019 | To: | 30 April 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 835,095 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 581,004 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 254,091 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline 2009 Share Option Plan - ADS | |||
Period of return: | From: | 1 November 2019 | To: | 30 April 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 5,391,416 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 698,736 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 4,692,680 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
Period of return: | From: | 1 November 2019 | To: | 30 April 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 2,145,812 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 698,407 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,447,405 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |